ArticleJournal of women's health (2002)2026
Prescription Medication Use Among Women Aged 40 and Older in the United States from 1999 to 2020.
Article in Journal of women's health (2002), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
importancePrescription medication use in the United States has increased over recent decades, with women consistently reporting higher use than men. However, limited research has examined use patterns among women, particularly those 40 years and older who face elevated risks for chronic disease.
objectiveTo assess prescription medication use among U.S. women 40 years and older. DESIGN/
settingCross-sectional analysis of National Health and Nutrition Examination Survey (NHANES) data from 10 survey cycles spanning 1999-2020.
participantsA total of 18,686 women aged 40 years and older with complete prescription medication information. EXPOSURE: Calendar year modeled as NHANES cycles. MAIN OUTCOME(S) AND MEASURE(S): Prescription medication use in the past 30 days, overall and by therapeutic class, was estimated for each NHANES cycle. Joinpoint regression estimated average annual percent change (APC). Logistic regression assessed associations between covariates and medication use and polypharmacy (≥5 medications).
resultsPolypharmacy among female participants rose from 17.9% in 1999-2000 to 26.0% in 2017-2020, demonstrating an increasing trend early (1999-2004 APC: 7.4, [95%CI: 1.9, 13.6]) followed by stable use (2004-2020 APC: 0.8 [-2.7, 1.9]). Increases in polypharmacy use occurred across racial and ethnic groups and were greatest among women aged 70-85 years. Cardiovascular (1999-2020 APC: 0.9 [0.4, 1.4]) and metabolic (1999-2006 APC: 7.9 [4.1, 15.8]) agent use increased across survey cycles while hormones/hormone modifier use declined (1999-2008 APC: -6.0 [-14.0, -1.3]). CONCLUSIONS AND RELEVANCE: Polypharmacy use increased among women 40 years and older, with notable shifts across therapeutic classes. These trends highlight the need for continued surveillance of medication patterns within this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.